Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Adjuvant Holdings CoTSE:4929 +0.41%59 EV-to-EBIT is 22.40 as of Aug. 30, 2026, which is 46% above its 10-year median of 15.36. GuruFocus rates TSE:4929 with a GF Score™ of 59/100 and a GF Value™ of 円730.87 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,567 Consumer Packaged Goods companies, Adjuvant Holdings Co ranks worse than 75.62% on this metric.
Adjuvant Holdings Co (TSE:4929) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Adjuvant Holdings Co's Enterprise Value for the quarter that ended in Mar. 2026 was 円3,896 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Adjuvant Holdings Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was 円171 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adjuvant Holdings Co EV-to-EBIT Related Terms
Adjuvant Holdings Co EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Adjuvant Holdings Co's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Adjuvant Holdings Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adjuvant Holdings Co EV-to-EBIT vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Adjuvant Holdings Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Adjuvant Holdings Co's EV-to-EBIT falls into.
Adjuvant Holdings Co's current Enterprise Value is 円3,824 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Adjuvant Holdings Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was 円171 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adjuvant Holdings Co (TSE:4929) has a EV-to-EBIT of 22.40 as of Aug. 30, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Adjuvant Holdings Co and its competitors. This is 46% above median its historical median of 15.36. According to the industry distribution chart, Adjuvant Holdings Co ranks #1185 out of 1567 companies in the Consumer Packaged Goods industry, placing it in the top 75.6%.
Is Adjuvant Holdings Co's EV-to-EBIT too high?
Adjuvant Holdings Co's current EV-to-EBIT of 22.40 is 46% above median its 10-year median of 15.36. The Consumer Packaged Goods industry median EV-to-EBIT is 12.44. Adjuvant Holdings Co's value of 22.40 is 80.1% above this industry median. Based on the distribution chart, Adjuvant Holdings Co ranks #1185 out of 1567 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Adjuvant Holdings Co has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Adjuvant Holdings Co's EV-to-EBIT compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Adjuvant Holdings Co ranks #1185 out of 1567 companies for EV-to-EBIT. This places Adjuvant Holdings Co in the lower half of its industry. The industry median EV-to-EBIT is 12.44. Adjuvant Holdings Co's value of 22.40 is 80.1% above this benchmark. While the company's 10-year median is 15.36 vs. the industry median of 12.44, Adjuvant Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Consumer Packaged Goods company?
The median EV-to-EBIT among Consumer Packaged Goods companies is 12.44, based on 1,567 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Adjuvant Holdings Co's current EV-to-EBIT of 22.40 is 80.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Adjuvant Holdings Co and its competitors. For the Consumer Packaged Goods industry, the median EV-to-EBIT is 12.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adjuvant Holdings Co's current EV-to-EBIT is 22.40, which is 46% above median its own 10-year median of 15.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adjuvant Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Adjuvant Holdings Co (TSE:4929) is currently considered Fairly Valued. The stock's GF Value™ is 円730.87, compared to a current price of 円742.00 — trading 1.5% above its estimated fair value. The current EV-to-EBIT is 22.40, which is 46% above median its 10-year median of 15.36 and 80.1% above the Consumer Packaged Goods industry median of 12.44. Adjuvant Holdings Co's overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Adjuvant Holdings Co (TSE:4929), the current EV-to-EBIT is 22.40 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adjuvant Holdings Co (TSE:4929) Overvalued in 2026?
Based on GuruFocus' analysis, Adjuvant Holdings Co stock appears to be overvalued.
The current stock price of 円742.00 is trading 1.5% above its estimated GF Value™ of 円730.87.
GuruFocus considers Adjuvant Holdings Co to be Fairly Valued.
Key valuation signals for TSE:4929:
EV-to-EBIT: 22.40 (46% above median its 10-year median of 15.36)
GF Value™: 円730.87 vs. price of 円742.00 (1.5% above fair value)
Industry Position: 80.1% above the Consumer Packaged Goods median (#1185 of 1567)
No single metric tells the full story. See the TSE:4929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adjuvant Holdings Co Ltd, formerly Adjuvant Cosme Japan Co Ltd is engaged in the research, development, production, and sale of cosmetics in Japan. It offers skin care products, including cleansing products, facial cleansers, lotions, beauty essences, masks, moisturizing creams, makeup bases, makeup, and body care products among other products.
59GF Score
Get the complete analysis for TSE:4929
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4929 has been successfully added to your 
